The Munich companies Amsilk produces synthetic silk from plant-based raw materials through bacterial fermentation. The material is used in applications including sportswear and medical implants. The silk biopolymers are fully recyclable and biodegradable.
“Amsilk is well positioned to become one of the world’s leading biomaterials companies”
With the help of money from its old and new investors, Amsilk aims to produce its silk polymers more quickly in industrial quantities and make them available to a wider range of customers and industries.
“With its strong team led by CEO Ulrich Scherbel and the support of its expanded investor base, Amsilk is well positioned to further scale its proven business model and become one of the world’s leading biomaterials companies,”
says Michael Motschmann, general partner of the investor MIG.
"We very much welcome the fact that our long-standing investment company is attracting such highly respected international investors who, like us, are convinced of the enormous potential of the technology and the business model."
